Canada markets closed

ARCA biopharma, Inc. (ABIO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.3125-0.0075 (-0.32%)
As of 10:57AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 33.43M
Enterprise Value -15.27M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.70
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.83

Trading Information

Stock Price History

Beta (5Y Monthly) 2.20
52-Week Change 3-28.83%
S&P500 52-Week Change 3-7.05%
52 Week High 33.9000
52 Week Low 31.7100
50-Day Moving Average 32.3338
200-Day Moving Average 32.4383

Share Statistics

Avg Vol (3 month) 3162k
Avg Vol (10 day) 395.01k
Shares Outstanding 514.41M
Implied Shares Outstanding 6N/A
Float 811.05M
% Held by Insiders 10.74%
% Held by Institutions 130.39%
Shares Short (Apr 28, 2022) 4219.86k
Short Ratio (Apr 28, 2022) 41
Short % of Float (Apr 28, 2022) 41.54%
Short % of Shares Outstanding (Apr 28, 2022) 41.53%
Shares Short (prior month Mar 30, 2022) 4283.72k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Apr 03, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:18
Last Split Date 3Apr 03, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-19.25%
Return on Equity (ttm)-32.49%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -18.49M
Net Income Avi to Common (ttm)-18.49M
Diluted EPS (ttm)-1.2830
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)49.06M
Total Cash Per Share (mrq)3.4
Total Debt (mrq)460k
Total Debt/Equity (mrq)0.96
Current Ratio (mrq)18.59
Book Value Per Share (mrq)3.33

Cash Flow Statement

Operating Cash Flow (ttm)-17.84M
Levered Free Cash Flow (ttm)-10.87M